Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 25, 2017 12:30 ET | Source: Adamas Pharmaceuticals, Inc.

FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™

EMERYVILLE, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Drug Products...